This ability to differentiate non–muscle-invasive from muscle invasive BCa was used to predict BCa upstaging at repeat TURBT in a recent prospective series (area under the receiver operating characteristic curve 0.93, 95% CI 0.87– 0.97) and therefore VI-RADS has been proposed for avoiding repeat TURBT according to the European Association of Urology guidelines. This may be particularly useful in cases lacking muscularis propria in the specimen or in the setting of a unifocal, small, high-grade Ta/T1 tumor, for which a preoperative VI-RADS score of 1–2 may indicate a low likelihood of tumor understaging and therefore patients may be quickly directed to appropriate adjuvant intravesical therapy for follow-up. This relatively safe approach might minimize potential exposure to COVID19 infection by avoiding a second hospital admission for a surgical procedure that is not devoid of possible complications

VI-RADS scoring criteria for alternative risk-adapted strategies in the management of bladder cancer during the COVID-19 pandemic / Panebianco, Valeria; Del Giudice, Francesco; Leonardo, Costantino; Sciarra, Alessandro; Catalano, Carlo; Catto, James W F. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - 78:1(2020), pp. 18-20. [10.1016/j.eururo.2020.04.043]

VI-RADS scoring criteria for alternative risk-adapted strategies in the management of bladder cancer during the COVID-19 pandemic

Panebianco, Valeria
Primo
;
Del Giudice, Francesco
Secondo
;
Leonardo, Costantino;Sciarra, Alessandro;Catalano, Carlo
Penultimo
;
2020

Abstract

This ability to differentiate non–muscle-invasive from muscle invasive BCa was used to predict BCa upstaging at repeat TURBT in a recent prospective series (area under the receiver operating characteristic curve 0.93, 95% CI 0.87– 0.97) and therefore VI-RADS has been proposed for avoiding repeat TURBT according to the European Association of Urology guidelines. This may be particularly useful in cases lacking muscularis propria in the specimen or in the setting of a unifocal, small, high-grade Ta/T1 tumor, for which a preoperative VI-RADS score of 1–2 may indicate a low likelihood of tumor understaging and therefore patients may be quickly directed to appropriate adjuvant intravesical therapy for follow-up. This relatively safe approach might minimize potential exposure to COVID19 infection by avoiding a second hospital admission for a surgical procedure that is not devoid of possible complications
2020
COVID-19; bladder cancer; magnetic resonance
01 Pubblicazione su rivista::01f Lettera, Nota
VI-RADS scoring criteria for alternative risk-adapted strategies in the management of bladder cancer during the COVID-19 pandemic / Panebianco, Valeria; Del Giudice, Francesco; Leonardo, Costantino; Sciarra, Alessandro; Catalano, Carlo; Catto, James W F. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - 78:1(2020), pp. 18-20. [10.1016/j.eururo.2020.04.043]
File allegati a questo prodotto
File Dimensione Formato  
Panebianco_VI-RADS Scoring_2020.pdf

accesso aperto

Note: https://www.europeanurology.com/article/S0302-2838(20)30306-7/fulltext
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 563 kB
Formato Adobe PDF
563 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1391740
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 24
social impact